Artificial intelligence news and machine learning news

News and Trends 16 Oct 2019

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to launch an AI tool that reduces the time it takes to develop treatments for rare diseases by five years. The Series B round was led by the UK VC firm Atomico and includes the returning investor Jonathan Milner, the founder […]

October 16, 2019 - 2 minutesmins - By Jonathan Smith

Switzerland Hôpitaux Universitaires Genève HUG

News and Trends 11 Sep 2019

IBM’s Watson for Genomics Launches in First European Hospital

The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […]

September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

adc therapeutics genomics sophia genetics blood cancer

News and Trends 6 Aug 2019

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

Two companies based in Lausanne, Switzerland — ADC Therapeutics and the genomics company SOPHiA Genetics — have signed a deal to identify patients most likely to respond to a blood cancer drug. ADC Therapeutics will send SOPHiA Genetics blood samples collected from an ongoing phase II trial. The trial is testing a treatment for patients […]

August 6, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. Many of the biotechs in the city are connected to the University of Lausanne (UNIL), as well as the renowned Swiss Federal Institute […]

May 8, 2019 - 7 minutesmins - By David Cox

sophia genetics ai genomics cancer diagnostic

News and Trends 11 Apr 2019

Swiss Multi-Cancer Diagnostic Test Approved in Europe

A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors by looking at genetic variations in 42 genes. SOPHiA GENETICS works in data-driven medicine, using huge amounts of genomic data to diagnose and personalize treatments to a patient. This new technology is being adopted by […]

April 11, 2019 - 2 minutesmins - By Jonathan Smith

Heptares AstraZeneka AZD4635 checkpoint inhibitor

News and Trends 27 Mar 2019

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop treatments for tumors that don’t respond to checkpoint inhibitor drugs. In the last five years, checkpoint inhibitor drugs have become a potentially life-saving option for people that don’t respond to traditional cancer treatments. These antibody drugs have shown promise in […]

March 27, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Mar 2019

Celgene and Exscientia Sign the Largest Deal in AI for Drug Discovery

In a deal with €22M paid upfront and undisclosed “substantial milestones and royalties,” Exscientia will use its artificial intelligence technology to help Celgene speed up the discovery of drug candidates for cancer and autoimmune diseases. “It is the largest AI drug discovery deal done in the industry to date,” said Andrew Hopkins, CEO of Oxford-based […]

March 21, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

arthritis pediatric juvenile idiopathic Leuven

News and Trends 13 Mar 2019

Artificial Intelligence Detects Juvenile Arthritis in the Blood

Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with almost 90% accuracy and identify different forms of the disease, something that is not currently possible. Juvenile idiopathic arthritis causes joint pain, swelling and stiffness in children under the age of 16. The disease is hard to treat because there […]

March 13, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2019

AI Drug Discovery Company Raises €23M and Signs with Roche

Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with Roche worth up to €60M. Exscientia has developed an artificial intelligence platform to boost drug discovery in pharma and biotech. “We can reduce at least 4- to 5-fold the time and cost of drug discovery as compared to the industry […]

January 7, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Jan 2019

Swiss Firm Raises €67M to Take Genomics AI to Hospitals

SOPHiA GENETICS has completed a $77M (€67M) funding round that will expand the use of its artificial intelligence technology for genomics into hospitals across the world. The funding will mainly go towards the recruitment of new employees. The goal is to increase the number of hospitals using SOPHiA’s AI technology, particularly in the US, where […]

January 7, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

genomics machine learning personalized medicine

More News! 10 Dec 2018

British Company Raises €37M to Personalize Therapies with Machine Learning

Genomics, a company based in Oxford, has increased the amount raised in a Series B round that will fund further development of its genomics technology for personalized medicine. The company adds a further €9M (£8M) to the round with the participation of Foresite Capital and F-Prime Capital, two renowned US life sciences investors. The previous […]

December 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Oct 2018

Microsoft Signs its First Microbiome Partnership

Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit our body are key to our health. The microbiome has been linked to conditions such as diabetes, cancer, Alzheimer’s, multiple sclerosis and many more. However, large-scale studies […]

October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial intelligence

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

IBM’s Watson for Genomics Launches in First European Hospital

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

Top 10 Biotechs in Lausanne

Swiss Multi-Cancer Diagnostic Test Approved in Europe

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

Celgene and Exscientia Sign the Largest Deal in AI for Drug Discovery

Artificial Intelligence Detects Juvenile Arthritis in the Blood

AI Drug Discovery Company Raises €23M and Signs with Roche

Swiss Firm Raises €67M to Take Genomics AI to Hospitals

British Company Raises €37M to Personalize Therapies with Machine Learning

Microsoft Signs its First Microbiome Partnership

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!